Home > Financial Ratios > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
EBIT Growth

    Back to All Ratios
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -27.45-8.272.0011.90-5.32

What is the latest EBIT Growth ratio of MEDICAMEN BIOTECH ?

The latest EBIT Growth ratio of MEDICAMEN BIOTECH is -27.45 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-27.45
Mar2024-8.27
Mar20232.00
Mar202211.90
Mar2021-5.32

How is EBIT Growth of MEDICAMEN BIOTECH Trending?

Years EBIT Growth % Change
Mar2025 -27.45
Negative
Mar2024 -8.27
Negative
Mar2023 2
-83.19
Mar2022 11.9
Positive
Mar2021 -5.32 -

Other Financial Ratios of MEDICAMEN BIOTECH


Compare EBIT Growth ratio of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹488.7 Cr 13% 8.5% -26.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,471.0 Cr 0.3% 4.1% -9.9% Stock Analytics
DIVIS LABORATORIES ₹172,294.0 Cr -1.7% 8.5% 13.2% Stock Analytics
CIPLA ₹127,946.0 Cr -3.4% 3% 4.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,691.0 Cr 0.7% -0.5% 7.2% Stock Analytics
DR REDDYS LABORATORIES ₹107,214.0 Cr 0.2% -1.1% -3.6% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

13%

8.5%

-26.9%

SENSEX

1%

3.3%

4.5%


You may also like the below Video Courses